Inhibrx Biosciences, Inc. (INBX)

CIK 2007919 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inhibrx Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20261440001959173-26-006886
Sep 10, 202640001202094-26-000004
Sep 9, 20261440001959173-26-006844
Sep 8, 20268-K0002007919-26-000047
Sep 8, 202640001240801-26-000004
Sep 8, 202640001366268-26-000004
Sep 8, 20261440001959173-26-006805
Sep 8, 202640001366074-26-000002
Aug 14, 2026SCHEDULE 13G/A0000905148-26-003736
Aug 14, 2026SCHEDULE 13G0001193805-26-001095
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352639
Aug 13, 202610-Q0002007919-26-000042
Aug 13, 20268-K0002007919-26-000044
Aug 3, 2026SCHEDULE 13G0000070858-26-000398
Jul 16, 20268-K0002007919-26-000037
Jun 15, 20268-K0002007919-26-000033
Jun 4, 202640001240801-26-000002
Jun 4, 202640001202094-26-000002
Jun 4, 202640001366268-26-000002
Jun 4, 202640001612627-26-000004
Jun 3, 20268-K0002007919-26-000030
May 15, 2026SCHEDULE 13G/A0001193125-26-226567
May 15, 2026SCHEDULE 13G/A0000905148-26-002437
May 14, 202610-Q0002007919-26-000027
May 14, 20268-K0002007919-26-000028